
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital - Moneycontrol.com
StrainX is a synthetic biology startup focused on developing innovative solutions in the field of biotechnology. The company aims to leverage advanced biological engineering techniques to create new products and processes. This funding round will help StrainX accelerate its growth and expand its research capabilities.
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital Moneycontrol.com
| May 23, 2026 | Uzbekistan National Investment Fund | $600.0M | — | Uzbekistan |
| May 23, 2026 | Vertical Aerospace | $850.0M | — | United Kingdom |
| May 22, 2026 | Trajektory | $8.0M | — | United States |
| May 22, 2026 | Africa Finance Corporation | $100.0M | — | Nigeria |